Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease

Lancet

Volumn 359, Issue 9302, 2002, Pages 227-228

  Quinlivan, E P ^a   McPartlin, J ^a   McNulty, H ^c   Ward, Mary ^c   Strain, J J ^c   Weir, D G ^a   Scott, J M ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLIC ACID BLOOD LEVEL; HEALTH CARE POLICY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VASCULAR DISEASE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 0037132839     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07439-1     Document Type: Article

References (5)

1. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects
2. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
3. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
4. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects